Figure 2
Impact of allelic or allele-group HLA-DPB1 disparities on OS after unrelated HSCT. Shown are Kaplan-Meier estimates of survival. (A) HLA-A, B, C, DRB1, and DQB1 matched transplantations (n = 242), stratified according to the presence (10 of 10; —) or absence (12 of 12; ) of allelic DPB1 mismatches. (B) Left panel: All HLA-DPB1 mismatched transplantations (n = 537), stratified according to the presence of TCE3-permissive (—) or TCE3-nonpermissive HvG () or GvH (dash-dot line) mismatches. Middle panel: TCE3-permissive transplantations (n = 287), subdivided into those permissive also according to TCE4 (—), or those TCE4-nonpermissive in HvG () or GvH (dash-dot line). Right panel: All HLA-DPB1 mismatched transplantations (n = 537), stratified according to the presence of TCE4-permissive (—) or TCE4-nonpermissive HvG () or GvH (dash-dot line) mismatches.

Impact of allelic or allele-group HLA-DPB1 disparities on OS after unrelated HSCT. Shown are Kaplan-Meier estimates of survival. (A) HLA-A, B, C, DRB1, and DQB1 matched transplantations (n = 242), stratified according to the presence (10 of 10; —) or absence (12 of 12; ) of allelic DPB1 mismatches. (B) Left panel: All HLA-DPB1 mismatched transplantations (n = 537), stratified according to the presence of TCE3-permissive (—) or TCE3-nonpermissive HvG () or GvH (dash-dot line) mismatches. Middle panel: TCE3-permissive transplantations (n = 287), subdivided into those permissive also according to TCE4 (—), or those TCE4-nonpermissive in HvG () or GvH (dash-dot line). Right panel: All HLA-DPB1 mismatched transplantations (n = 537), stratified according to the presence of TCE4-permissive (—) or TCE4-nonpermissive HvG () or GvH (dash-dot line) mismatches.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal